Dimension Research
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Neuroinflammation: Rethinking Treatment of Brain Disorders
After years of clinical setbacks and deprioritization in neuro drug development, could targeting the brain’s immune system as a new therapeutic…
Sep 4
•
Dimension
11
5
June 2025
ASCO 2025: Themes & Takeaways
After attending this year's ASCO conference, we've distilled a list of key concepts spanning checkpoint inhibition, TCR-inspired drugs, tackling…
Jun 18
•
Dimension
4
Enlicitide: A Curious(er) Macrocycle
Macrocyclic compounds lend themselves to interesting pharmacology. Merck's emerging PCSK9 inhibitor for "bad" cholesterol is no different. Will it…
Jun 13
•
Dimension
5
May 2025
Don't Fall in Love with Your Molecule
Technical success doesn't guarantee market success. This essay explores how target product profiles align discovery with demand to build enduring…
May 15
•
Dimension
19
4
February 2025
CTRL + ALT + DEPLETE
Resetting a dysfunctional immune system via the selective depletion of rogue cells is an emerging therapeutic strategy, having matured in the oncology…
Feb 24
•
Dimension
14
December 2024
NeurIPS 2024 Open Notes
Our team visited Vancouver to attend NeurIPS 2024. These are our initial notes from many of the AI x Biology workshops.
Dec 22, 2024
•
Dimension
9
MoML 2024 Open Notes
Our team recently attended the MoML Conference in Boston. We've curated a selection of our notes to push out into the open. Enjoy!
Dec 14, 2024
•
Dimension
8
2
October 2024
RMC-6236: A Curious Macrocycle
Macrocycles are a potent, intriguing class of therapies that are growing in importance. Revolution Medicines' RMC-6236 is a perfect example.
Oct 11, 2024
•
Dimension
8
1
September 2024
Cryptic Pockets: 'X' Marks the Spot
Cryptic binding pockets are like buried treasure. They're mysterious, difficult to find, and come with untold riches once surfaced.
Sep 13, 2024
•
Dimension
4
2
Unnatural Amino Acids
The extended amino acid alphabet is full of strangeness, but may hold the key to breakthrough applications in the life sciences.
Sep 5, 2024
•
Dimension
16
3
July 2024
Long Live Radiopharmaceuticals!
Radiotherapy is an oncological mainstay. Targeted radiopharmaceuticals are sweeping the clinical landscape, but face substantial hurdles to realize…
Jul 31, 2024
•
Dimension
3
June 2024
An Opinionated AlphaFold3 Field Guide
I break down every part of AlphaFold3 in simple-to-understand terms and give my observations and opinions along the way.
Jun 12, 2024
•
Dimension
21
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts